Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Pharma & Healthcare > Antipyretic Medicine for Elderly- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Antipyretic Medicine for Elderly- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Pharma & Healthcare

Published: 2026-03-09

Pages: 147 Pages

Report ld: 6072788

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Antipyretic Medicine for Elderly was estimated to be worth US$ 9602 million in 2025 and is projected to reach US$ 10930 million, growing at a CAGR of 1.9% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Antipyretic Medicine for Elderly cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Antipyretic Medicine for Elderly Market Size(US$)

M= millions and B=billions

Antipyretics for the elderly are antipyretics designed specifically for the elderly, and are mainly used to treat fever symptoms caused by infection (such as influenza, pneumonia), inflammation or other diseases. Its core goal is to lower body temperature by regulating the body temperature center or promoting heat dissipation, while strictly taking into account the physiological characteristics of the elderly and drug safety to avoid adverse drug reactions.

The North American market for Antipyretic Medicine for Elderly was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Antipyretic Medicine for Elderly was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Antipyretic Medicine for Elderly was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Antipyretic Medicine for Elderly market include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Antipyretic Medicine for Elderly, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Antipyretic Medicine for Elderly market size, estimations, and forecasts are presented in terms of sales volume (K Dose) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Antipyretic Medicine for Elderly.

Market Segmentation

Report Metric
Details
Report Title
Antipyretic Medicine for Elderly- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 10930 million
CAGR(2026-2032)
1.9%
Market Size Available for Years
2026-2032
Global Antipyretic Medicine for Elderly Companies Covered
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Mallinckrodt
Farmson
Granules India
SKPL
Atabay
Temad
Anqiu Lu'an
Zhejiang Kangle
Hebei Jiheng
Novacyl
Anhui Fubore
Anhui BBCA Likang
Changshu Huagang
Global Antipyretic Medicine for Elderly Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antipyretic Medicine for Elderly Market, Segment by Type
Acetaminophen
Ibuprofen
Other
Global Antipyretic Medicine for Elderly Market, Segment by Application
Online Sales
Offline Sales
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Antipyretic Medicine for Elderly manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Antipyretic Medicine for Elderly sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Antipyretic Medicine for Elderly sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Antipyretic Medicine for Elderly Product Introduction
    1.2 Global Antipyretic Medicine for Elderly Market Size Forecast
        1.2.1 Global Antipyretic Medicine for Elderly Sales Value (2021–2032)
        1.2.2 Global Antipyretic Medicine for Elderly Sales Volume (2021–2032)
        1.2.3 Global Antipyretic Medicine for Elderly Sales Price (2021–2032)
    1.3 Antipyretic Medicine for Elderly Market Trends & Drivers
        1.3.1 Antipyretic Medicine for Elderly Industry Trends
        1.3.2 Antipyretic Medicine for Elderly Market Drivers & Opportunities
        1.3.3 Antipyretic Medicine for Elderly Market Challenges
        1.3.4 Antipyretic Medicine for Elderly Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Antipyretic Medicine for Elderly Players Revenue Ranking (2025)
    2.2 Global Antipyretic Medicine for Elderly Revenue by Company (2021–2026)
    2.3 Global Antipyretic Medicine for Elderly Sales Volume Ranking of Players (2025)
    2.4 Global Antipyretic Medicine for Elderly Sales Volume by Company (2021–2026)
    2.5 Global Antipyretic Medicine for Elderly Average Price by Company (2021–2026)
    2.6 Key Manufacturers Antipyretic Medicine for Elderly Manufacturing Base and Headquarters
    2.7 Key Manufacturers Antipyretic Medicine for Elderly Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Antipyretic Medicine for Elderly
    2.9 Antipyretic Medicine for Elderly Market Competitive Analysis
        2.9.1 Antipyretic Medicine for Elderly Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Antipyretic Medicine for Elderly Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic Medicine for Elderly revenue, 2025
    2.10 Mergers & Acquisitions and Expansion

3 Segmentation Antipyretic Medicine for Elderly Market Classification
    3.1 Introduction by Type
        3.1.1 Acetaminophen
        3.1.2 Ibuprofen
        3.1.3 Other
        3.1.4 Global Antipyretic Medicine for Elderly Sales Value by Type
            3.1.4.1 Global Antipyretic Medicine for Elderly Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.4.2 Global Antipyretic Medicine for Elderly Sales Value, by Type (2021–2032)
            3.1.4.3 Global Antipyretic Medicine for Elderly Sales Value, by Type (%), 2021–2032
        3.1.5 Global Antipyretic Medicine for Elderly Sales Volume by Type
            3.1.5.1 Global Antipyretic Medicine for Elderly Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.5.2 Global Antipyretic Medicine for Elderly Sales Volume, by Type (2021–2032)
            3.1.5.3 Global Antipyretic Medicine for Elderly Sales Volume, by Type (%), 2021–2032
        3.1.6 Global Antipyretic Medicine for Elderly Average Price by Type (2021–2032)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Online Sales
        4.1.2 Offline Sales
    4.2 Global Antipyretic Medicine for Elderly Sales Value by Application
        4.2.1 Global Antipyretic Medicine for Elderly Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Antipyretic Medicine for Elderly Sales Value, by Application (2021–2032)
        4.2.3 Global Antipyretic Medicine for Elderly Sales Value, by Application (%), 2021–2032
    4.3 Global Antipyretic Medicine for Elderly Sales Volume by Application
        4.3.1 Global Antipyretic Medicine for Elderly Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global Antipyretic Medicine for Elderly Sales Volume, by Application (2021–2032)
        4.3.3 Global Antipyretic Medicine for Elderly Sales Volume, by Application (%), 2021–2032
    4.4 Global Antipyretic Medicine for Elderly Average Price by Application (2021–2032)

5 Segmentation by Region
    5.1 Global Antipyretic Medicine for Elderly Sales Value by Region
        5.1.1 Global Antipyretic Medicine for Elderly Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Antipyretic Medicine for Elderly Sales Value by Region (2021–2026)
        5.1.3 Global Antipyretic Medicine for Elderly Sales Value by Region (2027–2032)
        5.1.4 Global Antipyretic Medicine for Elderly Sales Value by Region (%), 2021–2032
    5.2 Global Antipyretic Medicine for Elderly Sales Volume by Region
        5.2.1 Global Antipyretic Medicine for Elderly Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Antipyretic Medicine for Elderly Sales Volume by Region (2021–2026)
        5.2.3 Global Antipyretic Medicine for Elderly Sales Volume by Region (2027–2032)
        5.2.4 Global Antipyretic Medicine for Elderly Sales Volume by Region (%), 2021–2032
    5.3 Global Antipyretic Medicine for Elderly Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Antipyretic Medicine for Elderly Sales Value, 2021–2032
        5.4.2 North America Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Antipyretic Medicine for Elderly Sales Value, 2021–2032
        5.5.2 Europe Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Antipyretic Medicine for Elderly Sales Value, 2021–2032
        5.6.2 Asia Pacific Antipyretic Medicine for Elderly Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Antipyretic Medicine for Elderly Sales Value, 2021–2032
        5.7.2 South America Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Antipyretic Medicine for Elderly Sales Value, 2021–2032
        5.8.2 Middle East & Africa Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Antipyretic Medicine for Elderly Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Antipyretic Medicine for Elderly Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Antipyretic Medicine for Elderly Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.3.2 United States Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.4.2 Europe Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.5.2 China Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.6.2 Japan Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.7.2 South Korea Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.8.2 Southeast Asia Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Antipyretic Medicine for Elderly Sales Value, 2021–2032
        6.9.2 India Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Antipyretic Medicine for Elderly Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 Xinhua Pharmaceutical
        7.1.1 Xinhua Pharmaceutical Company Information
        7.1.2 Xinhua Pharmaceutical Introduction and Business Overview
        7.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product Offerings
        7.1.5 Xinhua Pharmaceutical Recent Developments
    7.2 IOLCP
        7.2.1 IOLCP Company Information
        7.2.2 IOLCP Introduction and Business Overview
        7.2.3 IOLCP Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 IOLCP Antipyretic Medicine for Elderly Product Offerings
        7.2.5 IOLCP Recent Developments
    7.3 Granules Biocause
        7.3.1 Granules Biocause Company Information
        7.3.2 Granules Biocause Introduction and Business Overview
        7.3.3 Granules Biocause Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 Granules Biocause Antipyretic Medicine for Elderly Product Offerings
        7.3.5 Granules Biocause Recent Developments
    7.4 Strides Shasun
        7.4.1 Strides Shasun Company Information
        7.4.2 Strides Shasun Introduction and Business Overview
        7.4.3 Strides Shasun Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 Strides Shasun Antipyretic Medicine for Elderly Product Offerings
        7.4.5 Strides Shasun Recent Developments
    7.5 Mallinckrodt
        7.5.1 Mallinckrodt Company Information
        7.5.2 Mallinckrodt Introduction and Business Overview
        7.5.3 Mallinckrodt Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 Mallinckrodt Antipyretic Medicine for Elderly Product Offerings
        7.5.5 Mallinckrodt Recent Developments
    7.6 Farmson
        7.6.1 Farmson Company Information
        7.6.2 Farmson Introduction and Business Overview
        7.6.3 Farmson Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 Farmson Antipyretic Medicine for Elderly Product Offerings
        7.6.5 Farmson Recent Developments
    7.7 Granules India
        7.7.1 Granules India Company Information
        7.7.2 Granules India Introduction and Business Overview
        7.7.3 Granules India Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 Granules India Antipyretic Medicine for Elderly Product Offerings
        7.7.5 Granules India Recent Developments
    7.8 SKPL
        7.8.1 SKPL Company Information
        7.8.2 SKPL Introduction and Business Overview
        7.8.3 SKPL Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 SKPL Antipyretic Medicine for Elderly Product Offerings
        7.8.5 SKPL Recent Developments
    7.9 Atabay
        7.9.1 Atabay Company Information
        7.9.2 Atabay Introduction and Business Overview
        7.9.3 Atabay Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 Atabay Antipyretic Medicine for Elderly Product Offerings
        7.9.5 Atabay Recent Developments
    7.10 Temad
        7.10.1 Temad Company Information
        7.10.2 Temad Introduction and Business Overview
        7.10.3 Temad Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 Temad Antipyretic Medicine for Elderly Product Offerings
        7.10.5 Temad Recent Developments
    7.11 Anqiu Lu'an
        7.11.1 Anqiu Lu'an Company Information
        7.11.2 Anqiu Lu'an Introduction and Business Overview
        7.11.3 Anqiu Lu'an Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.11.4 Anqiu Lu'an Antipyretic Medicine for Elderly Product Offerings
        7.11.5 Anqiu Lu'an Recent Developments
    7.12 Zhejiang Kangle
        7.12.1 Zhejiang Kangle Company Information
        7.12.2 Zhejiang Kangle Introduction and Business Overview
        7.12.3 Zhejiang Kangle Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.12.4 Zhejiang Kangle Antipyretic Medicine for Elderly Product Offerings
        7.12.5 Zhejiang Kangle Recent Developments
    7.13 Hebei Jiheng
        7.13.1 Hebei Jiheng Company Information
        7.13.2 Hebei Jiheng Introduction and Business Overview
        7.13.3 Hebei Jiheng Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.13.4 Hebei Jiheng Antipyretic Medicine for Elderly Product Offerings
        7.13.5 Hebei Jiheng Recent Developments
    7.14 Novacyl
        7.14.1 Novacyl Company Information
        7.14.2 Novacyl Introduction and Business Overview
        7.14.3 Novacyl Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.14.4 Novacyl Antipyretic Medicine for Elderly Product Offerings
        7.14.5 Novacyl Recent Developments
    7.15 Anhui Fubore
        7.15.1 Anhui Fubore Company Information
        7.15.2 Anhui Fubore Introduction and Business Overview
        7.15.3 Anhui Fubore Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.15.4 Anhui Fubore Antipyretic Medicine for Elderly Product Offerings
        7.15.5 Anhui Fubore Recent Developments
    7.16 Anhui BBCA Likang
        7.16.1 Anhui BBCA Likang Company Information
        7.16.2 Anhui BBCA Likang Introduction and Business Overview
        7.16.3 Anhui BBCA Likang Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.16.4 Anhui BBCA Likang Antipyretic Medicine for Elderly Product Offerings
        7.16.5 Anhui BBCA Likang Recent Developments
    7.17 Changshu Huagang
        7.17.1 Changshu Huagang Company Information
        7.17.2 Changshu Huagang Introduction and Business Overview
        7.17.3 Changshu Huagang Antipyretic Medicine for Elderly Sales, Revenue, Price and Gross Margin (2021–2026)
        7.17.4 Changshu Huagang Antipyretic Medicine for Elderly Product Offerings
        7.17.5 Changshu Huagang Recent Developments

8 Industry Chain Analysis
    8.1 Antipyretic Medicine for Elderly Industrial Chain
    8.2 Antipyretic Medicine for Elderly Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Antipyretic Medicine for Elderly Sales Model
        8.5.2 Sales Channels
        8.5.3 Antipyretic Medicine for Elderly Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Antipyretic Medicine for Elderly Market Trends
 Table 2. Antipyretic Medicine for Elderly Market Drivers & Opportunities
 Table 3. Antipyretic Medicine for Elderly Market Challenges
 Table 4. Antipyretic Medicine for Elderly Market Restraints
 Table 5. Global Antipyretic Medicine for Elderly Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Antipyretic Medicine for Elderly Revenue Market Share by Company (2021–2026)
 Table 7. Global Antipyretic Medicine for Elderly Sales Volume by Company (K Dose), 2021–2026
 Table 8. Global Antipyretic Medicine for Elderly Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Antipyretic Medicine for Elderly Price by Company (US$/Dose), 2021–2026
 Table 10. Key Manufacturers Antipyretic Medicine for Elderly Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Antipyretic Medicine for Elderly Product Type
 Table 12. Key Manufacturers Start of Mass Production of Antipyretic Medicine for Elderly
 Table 13. Global Antipyretic Medicine for Elderly Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic Medicine for Elderly revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Antipyretic Medicine for Elderly Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Antipyretic Medicine for Elderly Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Antipyretic Medicine for Elderly Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Antipyretic Medicine for Elderly Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Antipyretic Medicine for Elderly Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Antipyretic Medicine for Elderly Sales Volume by Type: 2021 vs 2025 vs 2032 (K Dose)
 Table 22. Global Antipyretic Medicine for Elderly Sales Volume by Type (K Dose), 2021–2026
 Table 23. Global Antipyretic Medicine for Elderly Sales Volume by Type (K Dose), 2027–2032
 Table 24. Global Antipyretic Medicine for Elderly Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Antipyretic Medicine for Elderly Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Antipyretic Medicine for Elderly Price by Type (US$/Dose), 2021–2026
 Table 27. Global Antipyretic Medicine for Elderly Price by Type (US$/Dose), 2027–2032
 Table 28. Global Antipyretic Medicine for Elderly Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Antipyretic Medicine for Elderly Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Antipyretic Medicine for Elderly Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Antipyretic Medicine for Elderly Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Antipyretic Medicine for Elderly Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Antipyretic Medicine for Elderly Sales Volume by Application: 2021 vs 2025 vs 2032 (K Dose)
 Table 34. Global Antipyretic Medicine for Elderly Sales Volume by Application (K Dose), 2021–2026
 Table 35. Global Antipyretic Medicine for Elderly Sales Volume by Application (K Dose), 2027–2032
 Table 36. Global Antipyretic Medicine for Elderly Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Antipyretic Medicine for Elderly Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Antipyretic Medicine for Elderly Price by Application (US$/Dose), 2021–2026
 Table 39. Global Antipyretic Medicine for Elderly Price by Application (US$/Dose), 2027–2032
 Table 40. Global Antipyretic Medicine for Elderly Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Antipyretic Medicine for Elderly Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Antipyretic Medicine for Elderly Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Antipyretic Medicine for Elderly Sales Value by Region (%), 2021–2026
 Table 44. Global Antipyretic Medicine for Elderly Sales Value by Region (%), 2027–2032
 Table 45. Global Antipyretic Medicine for Elderly Sales Volume by Region (K Dose): 2021 vs 2025 vs 2032
 Table 46. Global Antipyretic Medicine for Elderly Sales Volume by Region (K Dose), 2021–2026
 Table 47. Global Antipyretic Medicine for Elderly Sales Volume by Region (K Dose), 2027–2032
 Table 48. Global Antipyretic Medicine for Elderly Sales Volume by Region (%), 2021–2026
 Table 49. Global Antipyretic Medicine for Elderly Sales Volume by Region (%), 2027–2032
 Table 50. Global Antipyretic Medicine for Elderly Average Price by Region (US$/Dose), 2021–2026
 Table 51. Global Antipyretic Medicine for Elderly Average Price by Region (US$/Dose), 2027–2032
 Table 52. Key Countries/Regions Antipyretic Medicine for Elderly Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Antipyretic Medicine for Elderly Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Antipyretic Medicine for Elderly Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Antipyretic Medicine for Elderly Sales Volume, (K Dose), 2021–2026
 Table 56. Key Countries/Regions Antipyretic Medicine for Elderly Sales Volume, (K Dose), 2027–2032
 Table 57. Xinhua Pharmaceutical Company Information
 Table 58. Xinhua Pharmaceutical Introduction and Business Overview
 Table 59. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 60. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product Offerings
 Table 61. Xinhua Pharmaceutical Recent Developments
 Table 62. IOLCP Company Information
 Table 63. IOLCP Introduction and Business Overview
 Table 64. IOLCP Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 65. IOLCP Antipyretic Medicine for Elderly Product Offerings
 Table 66. IOLCP Recent Developments
 Table 67. Granules Biocause Company Information
 Table 68. Granules Biocause Introduction and Business Overview
 Table 69. Granules Biocause Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 70. Granules Biocause Antipyretic Medicine for Elderly Product Offerings
 Table 71. Granules Biocause Recent Developments
 Table 72. Strides Shasun Company Information
 Table 73. Strides Shasun Introduction and Business Overview
 Table 74. Strides Shasun Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 75. Strides Shasun Antipyretic Medicine for Elderly Product Offerings
 Table 76. Strides Shasun Recent Developments
 Table 77. Mallinckrodt Company Information
 Table 78. Mallinckrodt Introduction and Business Overview
 Table 79. Mallinckrodt Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 80. Mallinckrodt Antipyretic Medicine for Elderly Product Offerings
 Table 81. Mallinckrodt Recent Developments
 Table 82. Farmson Company Information
 Table 83. Farmson Introduction and Business Overview
 Table 84. Farmson Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 85. Farmson Antipyretic Medicine for Elderly Product Offerings
 Table 86. Farmson Recent Developments
 Table 87. Granules India Company Information
 Table 88. Granules India Introduction and Business Overview
 Table 89. Granules India Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 90. Granules India Antipyretic Medicine for Elderly Product Offerings
 Table 91. Granules India Recent Developments
 Table 92. SKPL Company Information
 Table 93. SKPL Introduction and Business Overview
 Table 94. SKPL Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 95. SKPL Antipyretic Medicine for Elderly Product Offerings
 Table 96. SKPL Recent Developments
 Table 97. Atabay Company Information
 Table 98. Atabay Introduction and Business Overview
 Table 99. Atabay Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 100. Atabay Antipyretic Medicine for Elderly Product Offerings
 Table 101. Atabay Recent Developments
 Table 102. Temad Company Information
 Table 103. Temad Introduction and Business Overview
 Table 104. Temad Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 105. Temad Antipyretic Medicine for Elderly Product Offerings
 Table 106. Temad Recent Developments
 Table 107. Anqiu Lu'an Company Information
 Table 108. Anqiu Lu'an Introduction and Business Overview
 Table 109. Anqiu Lu'an Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 110. Anqiu Lu'an Antipyretic Medicine for Elderly Product Offerings
 Table 111. Anqiu Lu'an Recent Developments
 Table 112. Zhejiang Kangle Company Information
 Table 113. Zhejiang Kangle Introduction and Business Overview
 Table 114. Zhejiang Kangle Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 115. Zhejiang Kangle Antipyretic Medicine for Elderly Product Offerings
 Table 116. Zhejiang Kangle Recent Developments
 Table 117. Hebei Jiheng Company Information
 Table 118. Hebei Jiheng Introduction and Business Overview
 Table 119. Hebei Jiheng Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 120. Hebei Jiheng Antipyretic Medicine for Elderly Product Offerings
 Table 121. Hebei Jiheng Recent Developments
 Table 122. Novacyl Company Information
 Table 123. Novacyl Introduction and Business Overview
 Table 124. Novacyl Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 125. Novacyl Antipyretic Medicine for Elderly Product Offerings
 Table 126. Novacyl Recent Developments
 Table 127. Anhui Fubore Company Information
 Table 128. Anhui Fubore Introduction and Business Overview
 Table 129. Anhui Fubore Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 130. Anhui Fubore Antipyretic Medicine for Elderly Product Offerings
 Table 131. Anhui Fubore Recent Developments
 Table 132. Anhui BBCA Likang Company Information
 Table 133. Anhui BBCA Likang Introduction and Business Overview
 Table 134. Anhui BBCA Likang Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 135. Anhui BBCA Likang Antipyretic Medicine for Elderly Product Offerings
 Table 136. Anhui BBCA Likang Recent Developments
 Table 137. Changshu Huagang Company Information
 Table 138. Changshu Huagang Introduction and Business Overview
 Table 139. Changshu Huagang Antipyretic Medicine for Elderly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
 Table 140. Changshu Huagang Antipyretic Medicine for Elderly Product Offerings
 Table 141. Changshu Huagang Recent Developments
 Table 142. Key Raw Materials Lists
 Table 143. Key Suppliers of Raw Materials Lists
 Table 144. Antipyretic Medicine for Elderly Downstream Customers
 Table 145. Antipyretic Medicine for Elderly Distributors List
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources


List of Figures
 Figure 1. Antipyretic Medicine for Elderly Product Picture
 Figure 2. Global Antipyretic Medicine for Elderly Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 4. Global Antipyretic Medicine for Elderly Sales Volume (K Dose), 2021–2032
 Figure 5. Global Antipyretic Medicine for Elderly Sales Price (US$/Dose), 2021–2032
 Figure 6. Antipyretic Medicine for Elderly Report Years Considered
 Figure 7. Global Antipyretic Medicine for Elderly Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Antipyretic Medicine for Elderly Sales Volume Ranking of Players (K Dose), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antipyretic Medicine for Elderly Revenue in 2025
 Figure 10. Antipyretic Medicine for Elderly Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Acetaminophen Picture
 Figure 12. Ibuprofen Picture
 Figure 13. Other Picture
 Figure 14. Global Antipyretic Medicine for Elderly Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Antipyretic Medicine for Elderly Sales Value Market Share by Type, 2025 & 2032
 Figure 16. Global Antipyretic Medicine for Elderly Sales Volume by Type (K Dose), 2021 vs 2025 vs 2032
 Figure 17. Global Antipyretic Medicine for Elderly Sales Volume Market Share by Type, 2025 & 2032
 Figure 18. Global Antipyretic Medicine for Elderly Price by Type (US$/Dose), 2021–2032
 Figure 19. Product Picture of Online Sales
 Figure 20. Product Picture of Offline Sales
 Figure 21. Global Antipyretic Medicine for Elderly Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 22. Global Antipyretic Medicine for Elderly Sales Value Market Share by Application, 2025 & 2032
 Figure 23. Global Antipyretic Medicine for Elderly Sales Volume by Application (K Dose), 2021 vs 2025 vs 2032
 Figure 24. Global Antipyretic Medicine for Elderly Sales Volume Market Share by Application, 2025 & 2032
 Figure 25. Global Antipyretic Medicine for Elderly Price by Application (US$/Dose), 2021–2032
 Figure 26. North America Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 27. North America Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
 Figure 28. Europe Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 29. Europe Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
 Figure 30. Asia Pacific Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 31. Asia Pacific Antipyretic Medicine for Elderly Sales Value by Region (%), 2025 vs 2032
 Figure 32. South America Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 33. South America Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
 Figure 34. Middle East & Africa Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 35. Middle East & Africa Antipyretic Medicine for Elderly Sales Value by Country (%), 2025 vs 2032
 Figure 36. Key Countries/Regions Antipyretic Medicine for Elderly Sales Value (%), 2021–2032
 Figure 37. Key Countries/Regions Antipyretic Medicine for Elderly Sales Volume (%), 2021–2032
 Figure 38. United States Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 39. United States Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 40. United States Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 41. Europe Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 42. Europe Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 43. Europe Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 44. China Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 45. China Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 46. China Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 47. Japan Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 48. Japan Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 49. Japan Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 50. South Korea Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 51. South Korea Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 52. South Korea Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 53. Southeast Asia Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 54. Southeast Asia Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 55. Southeast Asia Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 56. India Antipyretic Medicine for Elderly Sales Value (US$ Million), 2021–2032
 Figure 57. India Antipyretic Medicine for Elderly Sales Value by Type (%), 2025 vs 2032
 Figure 58. India Antipyretic Medicine for Elderly Sales Value by Application (%), 2025 vs 2032
 Figure 59. Antipyretic Medicine for Elderly Industrial Chain
 Figure 60. Antipyretic Medicine for Elderly Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Antipyretic Medicine for Elderly was estimated to be worth US$ 9602 million in 2025 and is projected to reach US$ 10930 million, growing at a CAGR of 1.9% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Antipyretic Medicine for Elderly cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Antipyretics for the elderly are antipyretics designed specifically for the elderly, and are mainly used to treat fever symptoms caused by infection (such as influenza, pneumonia), inflammation or other diseases. Its core goal is to lower body temperature by regulating the body temperature center or promoting heat dissipation, while strictly taking into account the physiological characteristics of the elderly and drug safety to avoid adverse drug reactions.

The North American market for Antipyretic Medicine for Elderly was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Antipyretic Medicine for Elderly was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Antipyretic Medicine for Elderly was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Antipyretic Medicine for Elderly market include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Antipyretic Medicine for Elderly, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Antipyretic Medicine for Elderly market size, estimations, and forecasts are presented in terms of sales volume (K Dose) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Antipyretic Medicine for Elderly.

Market Segmentation

Related Reports

Global Antipyretic Medicine for Elderly Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antipyretic Medicine for Elderly market size was US$ 9589 million in 2024 and is forecast to a readjusted size of US$ 10750 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 101
USD 4250.00
(Single User License)
Global Antipyretic Medicine for Elderly Market Insights, Forecast to 2031
The global Antipyretic Medicine for Elderly market is projected to grow from US$ 9602 million in 2025 to US$ 10750 million by 2031, at a Compound Annual Growth Rate (CAGR) of 1.9% during the forecast period.
Published: 2025-05-08
Pages: 167
USD 4900.00
(Single User License)
Global Antipyretic Medicine for Elderly Market Research Report 2025
The global market for Antipyretic Medicine for Elderly was valued at US$ 9589 million in the year 2024 and is projected to reach a revised size of US$ 10750 million by 2031, growing at a CAGR of 1.9% during the forecast period.
Published: 2025-05-08
Pages: 106
USD 2900.00
(Single User License)
Antipyretic Medicine for Elderly - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antipyretic Medicine for Elderly was estimated to be worth US$ 9589 million in 2024 and is forecast to a readjusted size of US$ 10750 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 136
USD 3950.00
(Single User License)
Global Antipyretic Medicine for Elderly Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antipyretic Medicine for Elderly market size was US$ 9602 million in 2025 and is forecast to reach a readjusted size of US$ 10930 million by 2032 with a CAGR of 1.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Global Antipyretic Medicine for Elderly Market Research Report 2026
The global Antipyretic Medicine for Elderly market was valued at US$ 9602 million in 2025 and is anticipated to reach US$ 10930 million by 2032, at a CAGR of 1.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 130
USD 2900.00
(Single User License)
Global Antipyretic Medicine for Elderly Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antipyretic Medicine for Elderly market is projected to grow from US$ 9602 million in 2025 to US$ 10930 million by 2032, at a CAGR of 1.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 178
USD 4900.00
(Single User License)

Global Antipyretic Medicine for Elderly Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antipyretic Medicine for Elderly market size was US$ 9589 million in 2024 and is forecast to a readjusted size of US$ 10750 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 101
USD 4250.00 ()
Global Antipyretic Medicine for Elderly Market Insights, Forecast to 2031
The global Antipyretic Medicine for Elderly market is projected to grow from US$ 9602 million in 2025 to US$ 10750 million by 2031, at a Compound Annual Growth Rate (CAGR) of 1.9% during the forecast period.
Published: 2025-05-08
Pages: 167
USD 4900.00 ()
Global Antipyretic Medicine for Elderly Market Research Report 2025
The global market for Antipyretic Medicine for Elderly was valued at US$ 9589 million in the year 2024 and is projected to reach a revised size of US$ 10750 million by 2031, growing at a CAGR of 1.9% during the forecast period.
Published: 2025-05-08
Pages: 106
USD 2900.00 ()
Antipyretic Medicine for Elderly - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antipyretic Medicine for Elderly was estimated to be worth US$ 9589 million in 2024 and is forecast to a readjusted size of US$ 10750 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 136
USD 3950.00 ()
Global Antipyretic Medicine for Elderly Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antipyretic Medicine for Elderly market size was US$ 9602 million in 2025 and is forecast to reach a readjusted size of US$ 10930 million by 2032 with a CAGR of 1.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 ()
Global Antipyretic Medicine for Elderly Market Research Report 2026
The global Antipyretic Medicine for Elderly market was valued at US$ 9602 million in 2025 and is anticipated to reach US$ 10930 million by 2032, at a CAGR of 1.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 130
USD 2900.00 ()
Global Antipyretic Medicine for Elderly Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antipyretic Medicine for Elderly market is projected to grow from US$ 9602 million in 2025 to US$ 10930 million by 2032, at a CAGR of 1.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 178
USD 4900.00 ()